Showing 1541-1550 of 1614 results for "".
- Ophthalmic Investment Funds Led by Retinal Gene Therapy Developershttps://modernod.com/news/ophthalmic-investment-funds-led-by-retinal-gene-therapy-developers/2476147/Ophthalmology remains one of the most active areas of medical technology investment, attracting monies from venture capitalists, public markets, large ophthalmic companies, and private equity. Market Scope just published its 2017/2018 Ophthalmic Deals Book, analyzing recent ophthalmic fund
- Study: Dietary Supplements Don’t Prevent Chronic Diseasehttps://modernod.com/news/study-dietary-supplements-dont-prevent-chronic-disease/2476158/As the US nutritional and dietary supplements market remains robust — an estimated $41.1 billion in sales in 2016 — the Academy of Nutrition and Dietetics is cautioning against the routine and indiscriminate use of these dietary add-ons, according to a Medscape
- Sangamo Announces Completion of TxCell Acquisitionhttps://modernod.com/news/sangamo-announces-completion-of-txcell-acquisition/2476169/Sangamo Therapeutics announced the completion of the acquisition of TxCell, which is now a subsidiary of Sangamo and has been delisted from the French stock market. “The acquisition of
- EyeCare Partners Acquires Holcomb Laser Centerhttps://modernod.com/news/eyecare-partners-acquires-holcomb-laser-center/2479632/EyeCare Partners (ECP) furthered its expansion into the Alabama ophthalmology market with the acquisition of Dr. William Holcomb’s Cullman, Alabama-based Holcomb Laser Center, according to an announcement from EyeCare Partners, as reported in VisionMonday. Terms of the deal were not disclo
- FDA Revamping Clearance Procedures for Medical Deviceshttps://modernod.com/news/fda-revamping-clearance-procedures-for-medical-devices/2479649/The FDA is significantly revamping the way it clears most medical devices for U.S. marketing, planning to rely far less on comparisons with much older products already on the market, according to a
- Oculis Appoints New Members of Senior Management Teamhttps://modernod.com/news/oculis-appoints-new-members-of-senior-management-team/2479655/Oculis announced the appointments of Fabio Baschiera, PharmD, MPh, PhD, as Vice President of Clinical Development, and Louie-Anne Gauthier, M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing. “We are delighted to welcome Fabio and Louie-Anne to the Oculis m
- Millennial Demographics Drive Refractive Surgery Opportunity in UShttps://modernod.com/news/millennial-demographics-drive-refractive-surgery-opportunity-in-us/2479686/Wealth, health, and education are key factors in determining the opportunity for laser vision correction (LVC) procedures in the US, according to new Market Scope data. Refractive procedures are strongly driven by the country’s millennial population, and the high opportunity population is
- Webinar Today: Create a Winning Search Strategy for LASIK Practiceshttps://modernod.com/news/webinar-today-create-a-winning-search-strategy-for-lasik-practices/2479691/Workshop Digital, a digital marketing company in Virginia, and Google have partnered to host a live webinar at 4
- EMA Accepts Drug Application for Regulatory Approval of Rhokiinsa (Rhopressa)https://modernod.com/news/ema-accepts-drug-application-for-regulatory-approval-of-rhokiinsa-rhopressa/2479802/Aerie Pharmaceuticals reported that the European Medicines Agency (EMA) has accepted for review the MAA for Rhokiinsa (netarsudil ophthalmic solution) 0.02%. Rhokiinsa is currently marketed as Rhopressa in the United States and is indicated for the reduction of elevated IOP in patients with open-
- The Vision Council Conducts Study on Contact Lens Subscription Serviceshttps://modernod.com/news/the-vision-council-conducts-study-on-contact-lens-subscription-services/2479830/The Vision Council’s market research team has developed an industry first look at the new and emerging contact lens subscription services. This study aims to examine the potential impact on the contact lens and optical retail industries. “We have recently seen several new contact lens subs